STYLCONNECT Study: An Assessment of Automatic Data Collection Devices by People Living with Diabetes and Using an Insulin Pen

por Naïditch, Nicolas, Mauchant, Christine, Benabbad, Imane, Hehn, Coline, Joubert, Michael, Thébaut, Jean-François, Rosilio, Myriam
Publicado 2022

Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature

por Benabbad, Imane, Rosilio, Myriam, Tauber, Maité, Paris, Emmanuel, Paulsen, Anne, Berggren, Lovisa, Patel, Hiren, Carel, Jean-Claude
Publicado 2018

Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis

por Zimner Rapuch, Sarah, Divino, Victoria, Norrbacka, Kirsi, Boye, Kristina, Lebrec, Jeremie, Rosilio, Myriam, DeKoven, Mitch, Guerci, Bruno
Publicado 2021

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes

por Boye, Kristina S., Sapin, Hélène, García-Pérez, Luis-Emilio, Rosilio, Myriam, Orsini Federici, Marco, Heitmann, Elke, Jung, Heike, Aigner, Ulrich, Guerci, Bruno, Giorgino, Francesco, Norrbacka, Kirsi
Publicado 2020

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

por García-Pérez, Luis-Emilio, Boye, Kristina S., Rosilio, Myriam, Jung, Heike, Heitmann, Elke, Norrbacka, Kirsi, Federici, Marco Orsini, Gentilella, Raffaella, Guerci, Bruno, Giorgino, Francesco, Aigner, Ulrich, Sapin, Hélène
Publicado 2021

Producing a preference‐based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: A mixed‐methods research protocol

por Carlton, Jill, Powell, Philip, Rowen, Donna, Broadley, Melanie, Pouwer, Frans, Speight, Jane, Heller, Simon, Gall, Mari‐Anne, Rosilio, Myriam, Child, Christopher J., Comins, Jonathan, McCrimmon, Rory J., de Galan, Bastiaan, Brazier, John
Publicado 2022